- Diagnosis &
- Family Building
- Support &
- Give Back
- Get Involved
Guidelines updated to protect mother and baby further demonstrating the need for insurance coverage
(McLean, VA, October 19, 2009) — As the leading voice for women and men facing infertility, RESOLVE: The National Infertility Association (RESOLVE) applauds the American Society for Reproductive Medicine (ASRM) in their careful review and release of new guidelines for embryo transfers. These guidelines are developed to insure a healthy pregnancy and baby for infertility patients undergoing in vitro fertilization (IVF), while reducing the risk of multiple births.
The guidelines were updated in two important ways: regardless of the infertility causing condition, only one more embryo than called for in the previous guidelines should be transferred, and patients should be counseled about the risk to the mother and babies of a multiple birth. Both of these factors must be documented in the patient’s medical records.
As the patient voice, RESOLVE’s goal is to make sure that the 7.3 million Americans fighting the disease of infertility are informed of these guidelines and have a discussion regarding their treatment plan with their reproductive endocrinologist. These guidelines encourage healthcare professionals and patients to talk about the patient’s medical treatment early in the process and enable for patients to take charge of their infertility.
“RESOLVE applauds the American Society for Reproductive Medicine for updating the embryo transfer guidelines. RESOLVE understands the pressure on patients who must pay out-of-pocket for this life-affirming medical treatment that is often not covered by insurance. Because RESOLVE is committed to a healthy mother and baby, RESOLVE will continue to fight for insurance coverage for IVF and access to affordable care,” said Barbara Collura, Executive Director for RESOLVE.
RESOLVE supports the Family Building Act (S.1258/H.R. 687) now pending in Congress. This legislation requires insurance carriers to provide benefits for the highly effective ART treatments such as (IVF) and Intracytoplasmic Sperm Injection (ICSI). In addition, the bill does not confine eligibility for coverage within a certain age range.
For more information on RESOLVE, visit RESOLVE’s website at www.resolve.org. To interview an expert on the patients’ voice in infertility, contact Shawn Taylor Zelman at 703.556.7172, email@example.com.
About RESOLVE: The National Infertility Association
Founded in 1974, RESOLVE: The National Infertility Association, headquartered in McLean, VA, is the oldest and largest consumer-based, nonprofit group that provides education, advocacy and compassionate support for those struggling with infertility in the United States. Each year, RESOLVE and its nationwide network of affiliates handle more than 1.5 million contacts from people seeking information and help. For more information, visit the RESOLVE website at www.resolve.org.